Literature DB >> 3955884

Serum immunoglobulin G subclass dysbalances in the lymphadenopathy syndrome and acquired immune deficiency syndrome.

P Aucouturier, L J Couderc, D Gouet, F Danon, J Gombert, S Matheron, A G Saimot, J P Clauvel, J L Preud'homme.   

Abstract

Serum IgG subclass levels were measured by an indirect competitive immunoenzymatic assay with monoclonal antibodies in 61 adult patients of different geographic origins affected either with the lymphoadenopathy syndrome (LAS, 46 cases) or with the acquired immune deficiency syndrome (AIDS, 15 cases). In spite of considerable variations from patient to patient, IgG-1 and IgG-3 levels were higher than in normal Caucasians, with IgG-1 levels much more elevated in LAS than in AIDS patients. In Caucasians with AIDS or LAS, IgG-4 levels were low. IgG-2 levels tended to be low and correlated negatively with IgG-1 levels. IgG subclass imbalances were especially striking in patients with lymphoid interstitial pneumonitis. The results suggest that the IgG increase predominantly affects the less T-dependent subclasses. The low levels of the more T-dependent isotypes do not appear to play a clear role in the occurrence of pyogenic infections in certain patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3955884      PMCID: PMC1577345     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  IgG subclass expression by human B lymphocytes and plasma cells: B lymphocytes precommitted to IgG subclass can be preferentially induced by polyclonal mitogens with T cell help.

Authors:  M Mayumi; T Kuritani; H Kubagawa; M D Cooper
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

2.  Immunoglobulin C-gene expression. I. The commitment to IgG subclass of secretory cells is determined by the quality of the nonspecific stimuli.

Authors:  C Martinez-Alonso; A Coutinho; A A Augustin
Journal:  Eur J Immunol       Date:  1980-09       Impact factor: 5.532

3.  Immunoglobulin G subclass restriction of antibodies against hepatitis B surface antigen.

Authors:  A Morell; B Roth-Wicky; F Skvaril
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

4.  Immunologic abnormalities in homosexual men. Relationship to Kaposi's sarcoma.

Authors:  R E Stahl; A Friedman-Kien; R Dubin; M Marmor; S Zolla-Pazner
Journal:  Am J Med       Date:  1982-08       Impact factor: 4.965

5.  Lymphoid interstitial pneumonitis in acquired immunodeficiency syndrome-related complex.

Authors:  P Solal-Celigny; L J Couderc; D Herman; P Herve; L Schaffar-Deshayes; F Brun-Vezinet; G Tricot; J P Clauvel
Journal:  Am Rev Respir Dis       Date:  1985-06

6.  IgG subclass levels in malaria-infected Nigerians.

Authors:  L S Salimonu; A I Williams; B O Osunkoya
Journal:  Vox Sang       Date:  1982       Impact factor: 2.144

7.  Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers.

Authors:  A Rubinstein; M Sicklick; A Gupta; L Bernstein; N Klein; E Rubinstein; I Spigland; L Fruchter; N Litman; H Lee; M Hollander
Journal:  JAMA       Date:  1983-05-06       Impact factor: 56.272

8.  Immune deficiency syndrome in children.

Authors:  J Oleske; A Minnefor; R Cooper; K Thomas; A dela Cruz; H Ahdieh; I Guerrero; V V Joshi; F Desposito
Journal:  JAMA       Date:  1983-05-06       Impact factor: 56.272

9.  T cell regulation of immunoglobulin class expression in the antibody response to trinitrophenyl-ficoll. Evidence for T cell enhancement of the immunoglobulin class switch.

Authors:  P K Mongini; W E Paul; E S Metcalf
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

10.  Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers.

Authors:  W J Yount; M M Dorner; H G Kunkel; E A Kabat
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  25 in total

Review 1.  Therapeutic strategies in common variable immunodeficiency.

Authors:  W A Carrock Sewell; Matthew Buckland; Stephen R A Jolles
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.

Authors:  S Resino; I Galán; A Pérez; J A León; E Seoane; D Gurbindo; M Angeles Muñoz-Fernandez
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

Review 3.  Antibody responses in HIV infection.

Authors:  A J Pinching
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

4.  Altered IgG-subclass distribution in lymph node cells and serum of adults infected with human immunodeficiency virus (HIV).

Authors:  F Müller; S S Frøland; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

5.  Immunoglobulin G subclass levels and antibody responses to the 2009 influenza A (H1N1) monovalent vaccine among human immunodeficiency virus (HIV)-infected and HIV-uninfected adults.

Authors:  N F Crum-Cianflone; G Collins; G Defang; E Iverson; L E Eberly; C Duplessis; J Maguire; A Ganesan; B K Agan; T Lalani; T Whitman; C Brandt; D Faix; P J Blair; T Burgess
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

6.  Abnormal antibody responses in patients with persistent generalized lymphadenopathy.

Authors:  H D Ochs; A K Junker; A C Collier; F S Virant; H H Handsfield; R J Wedgwood
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

7.  IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages.

Authors:  K Ljunggren; P A Broliden; L Morfeldt-Månson; M Jondal; B Wahren
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

Review 8.  Does intravenous immune globulin have a role in HIV-infected patients?

Authors:  P L Yap
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

9.  In vitro anti-HIV-1 antibody production in subjects in different stages of HIV-1 infection.

Authors:  S Rusconi; A Riva; L Meroni; G Zehender; F Cocchi; L Scapellato; M Galli
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

10.  Serum IgG subclass deficiency in ataxia-telangiectasia.

Authors:  P Aucouturier; C Bremard-Oury; C Griscelli; M Berthier; J L Preud'homme
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.